Merozoite Surface Protein 1
"Merozoite Surface Protein 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A surface protein found on Plasmodium species which induces a T-cell response. The antigen is polymorphic, sharing amino acid sequence homology among PLASMODIUM FALCIPARUM; PLASMODIUM CHABAUDI; PLASMODIUM VIVAX; and PLASMODIUM YOELII.
| Descriptor ID |
D020066
|
| MeSH Number(s) |
D12.776.820.500 D23.050.293.500
|
| Concept/Terms |
Merozoite Surface Protein 1- Merozoite Surface Protein 1
- MSA-1 Protein
- MSA 1 Protein
- Protein, MSA-1
- MSP-1
- Plasmodium falciparum Merozoite Precursor Surface Coat Protein
- Major Merozoite Surface Protein Precursor
- Merozoite Surface Protein-1
- Surface Protein-1, Merozoite
- MSA1
- MSA1 Protein
- Protein, MSA1
- PFM-PSCP
- PMMSA
- MSP1
- MSA-1
- Merozoite Surface Antigen 1
|
Below are MeSH descriptors whose meaning is more general than "Merozoite Surface Protein 1".
Below are MeSH descriptors whose meaning is more specific than "Merozoite Surface Protein 1".
This graph shows the total number of publications written about "Merozoite Surface Protein 1" by people in this website by year, and whether "Merozoite Surface Protein 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1996 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 2002 | 2 | 1 | 3 |
| 2005 | 2 | 0 | 2 |
| 2006 | 3 | 0 | 3 |
| 2007 | 0 | 1 | 1 |
| 2008 | 5 | 0 | 5 |
| 2009 | 1 | 0 | 1 |
| 2010 | 3 | 0 | 3 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Merozoite Surface Protein 1" by people in Profiles.
-
Tassi Yunga S, Siriwardhana C, Fouda GG, Bobbili N, Sama G, Chen JJ, Leke RFG, Taylor DW. Characterization of the primary antibody response to Plasmodium falciparum antigens in infants living in a malaria-endemic area. Malar J. 2022 Nov 19; 21(1):346.
-
Lloyd YM, Fang R, Bobbili N, Vanda K, Ngati E, Sanchez-Quintero MJ, Salanti A, Chen JJ, Leke RGF, Taylor DW. Association of Antibodies to VAR2CSA and Merozoite Antigens with Pregnancy Outcomes in Women Living in Yaound?, Cameroon. Infect Immun. 2018 09; 86(9).
-
Taylor DW, Bobbili N, Khadka VS, Quakyi IA, Leke RG. Individuals living in a malaria-endemic area of Cameroon do not have an acquired antibody response to Plasmodium falciparum histidine-rich protein 2. Malar J. 2017 02 01; 16(1):58.
-
Pusic K, Aguilar Z, McLoughlin J, Kobuch S, Xu H, Tsang M, Wang A, Hui G. Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine. FASEB J. 2013 Mar; 27(3):1153-66.
-
Pusic K, Xu H, Stridiron A, Aguilar Z, Wang A, Hui G. Blood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodies. Vaccine. 2011 Nov 08; 29(48):8898-908.
-
Pusic KM, Hashimoto CN, Lehrer A, Aniya C, Clements DE, Hui GS. T cell epitope regions of the P. falciparum MSP1-33 critically influence immune responses and in vitro efficacy of MSP1-42 vaccines. PLoS One. 2011; 6(9):e24782.
-
Lau OS, Ng DW, Chan WW, Chang SP, Sun SS. Production of the 42-kDa fragment of Plasmodium falciparum merozoite surface protein 1, a leading malaria vaccine antigen, in Arabidopsis thaliana seeds. Plant Biotechnol J. 2010 Dec; 8(9):994-1004.
-
Omosun YO, Adoro S, Anumudu CI, Odaibo A, Holder AA, Nwagwu M, Nwuba RI. Total immunoglobulin G and IgG1 subclass levels specific for the MSP-1(19) of Plasmodium falciparum are different in individuals with either processing-inhibitory, blocking or neutral antibodies. Afr Health Sci. 2010 Jun; 10(2):106-10.
-
Chang SP, Kayatani AK, Terrientes ZI, Herrera S, Leke RG, Taylor DW. Shift in epitope dominance of IgM and IgG responses to Plasmodium falciparum MSP1 block 4. Malar J. 2010 Jan 13; 9:14.
-
Okafor CM, Anumudu CI, Omosun YO, Uthaipibull C, Ayede I, Awobode HO, Odaibo AB, Langhorne J, Holder AA, Nwuba RI, Troye-Blomberg M. Cellular responses to modified Plasmodium falciparum MSP119 antigens in individuals previously exposed to natural malaria infection. Malar J. 2009 Nov 23; 8:263.